Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03769610 · ClinicalTrials.gov registry record · NA

Inpatient Versus Outpatient Cervical Ripening

A NA study, sponsored by LifeBridge Health.

Terminated
Registry status
NA
Development phase
30
Enrollment target

NCT03769610 is a NA study that was terminated before completion, run by LifeBridge Health. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03769610, a NA study, was terminated before completion, sponsored by LifeBridge Health.

TERMINATED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Induction of labor is a process of stimulating uterine contractions before the onset of labor, with a goal of achieving vaginal birth. The cervix (the lower part of the uterus that connects to the vagina) must dilate (open) in order to allow passage of the baby into the vagina and through the birth canal. A process called "cervical ripening" is often performed prior to labor induction to prepare the cervix for labor and therefore shorten the length of the labor. There are various pharmacologic and mechanical methods of cervical ripening that result in the physical softening and distensibility of the cervix. Mechanical dilation with a small balloon (i.e. a Foley catheter) placed in the cervix is one of the most commonly used, safe, inexpensive, and effective methods to achieve cervical ripening. In most hospitals, cervical ripening is performed in the hospitals; however, some hospitals allow women to undergo cervical ripening at home with a transcervical Foley catheter. The goal of this study is to compare the use of a Foley catheter for cervical ripening in the inpatient (in-hospital) and outpatient (at home) settings. We anticipate that outpatient use will lead to a shorter amount of time that a woman spends in the hospital, decreased cost, and good patient satisfaction.

Interventions

  • OTHER Inpatient Foley catheter
  • OTHER Outpatient Foley catheter

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-01-04
Est. Completion 2021-04-01
Phase NA

Sponsor

LifeBridge Health

14 total trials

What the Registry Record Tells You About NCT03769610

The ClinicalTrials.gov registry entry for NCT03769610 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Inpatient Foley catheter is the first listed.

NCT03769610 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03769610 about?

NCT03769610 is a clinical study titled "Inpatient Versus Outpatient Cervical Ripening". Induction of labor is a process of stimulating uterine contractions before the onset of labor, with a goal of achieving vaginal birth. The cervix (the lower part of the uterus that connects to the vagina) must dilate (open) in order to allow passage of the baby into the vagina and through the birth ...

What is the current status of trial NCT03769610?

This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2017-01-04. Estimated completion is 2021-04-01.

What interventions are being tested in trial NCT03769610?

The interventions under investigation include: Inpatient Foley catheter (OTHER), Outpatient Foley catheter (OTHER).

Who is sponsoring clinical trial NCT03769610?

This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.